(May 23, 2017, 1:44 PM EDT) -- CHICAGO — The Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on May 22 struck defendant AbbVie Inc.’s motion for summary judgment in the first bellwether trial after ruling that the defendant waived its statute of limitations and statute of repose defenses by raising them only weeks before the June 5 trial (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, Jeffrey Konrad v. AbbVie, Inc., No. 15-966, N.D. Ill., E. Div.)....